Zhao, Y., Vavouraki, N., Lovering, R. C., Escott-Price, V., Harvey, K., Lewis, P. A., & Manzoni, C. (2023). Tissue specific LRRK2 interactomes reveal a distinct striatal functional unit. PLoS Computational Biology, 19 (1), e1010847. doi:10.1371/journal.pcbi.1010847

Lewis, P. (2022). A step forward for LRRK2 inhibitors in Parkinson’s disease. Science Translational Medicine. doi:10.1126/scitranslmed.abq7374

Cogo, S., Tomkins, J. E., Vavouraki, N., Giusti, V., Forcellato, F., Franchin, C., . . . Greggio, E. (2022). Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins. Neurobiology of Disease, 174, 105858. doi:10.1016/j.nbd.2022.105858

Kluss, J. H., Bonet-Ponce, L., Lewis, P. A., & Cookson, M. R. (2022). Directing LRRK2 to membranes of the endolysosomal pathway triggers RAB phosphorylation and JIP4 recruitment. Neurobiol Dis, 170, 105769. doi:10.1016/j.nbd.2022.105769

Kluss, J. H., Lewis, P. A., & Greggio, E. (2022). Leucine-rich repeat kinase 2 (LRRK2): an update on the potential therapeutic target for Parkinson’s disease. Expert Opinion on Therapeutic Targets, 1-10. doi:10.1080/14728222.2022.2082937

Kluss, J. H., Beilina, A., Williamson, C. D., Lewis, P. A., Cookson, M. R., & Bonet-Ponce, L. (2022). Lysosomal positioning regulates Rab10 phosphorylation at LRRK2⁺ lysosomes. Proceedings of the National Academy of Sciences of the United States of America, 119 (43). doi:10.1073/pnas.2205492119

Lewis, P. A. (2022). Prions. American Chemical Society. doi:10.1021/acsinfocus.7e5002

Soutar, M. P. M., Melandri, D., O'Callaghan, B., Annuario, E., Monaghan, A. E., Welsh, N. J., . . . Plun-Favreau, H. (2022). Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at 16q11.2 and MAPT H1 loci. Brain, awac325. doi:10.1093/brain/awac325

Ruz, C., Alcantud, J. L., Vives, F., Arrebola, F., Hardy, J., Lewis, P. A., . . . Duran, R. (2022). Seventy-Two-Hour LRRK2 Kinase Activity Inhibition Increases Lysosomal GBA Expression in H4, a Human Neuroglioma Cell Line. International Journal of Molecular Sciences, 23 (13), 6935. doi:10.3390/ijms23136935

Herbst, S., Lewis, P. A., & Morris, H. R. (2022). The emerging role of LRRK2 in tauopathies. Clinical Science, 136 (13), 1071-1079. doi:10.1042/CS20220067